Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups

Heather J. Whitaker, Ruby S.M. Tsang, Rachel Byford, Nick J. Andrews, Julian Sherlock, Praveen Sebastian Pillai, John Williams, Elizabeth Button, Helen Campbell, Mary Sinnathamby, William Victor, Sneha Anand, Ezra Linley, Jacqueline Hewson, Silvia DArchangelo, Ashley D. Otter, Joanna Ellis, Richard F.D. Hobbs, Gary Howsam, Maria ZambonMary Ramsay, Kevin E. Brown, Simon de Lusignan, Gayatri Amirthalingam, Jamie Lopez Bernal*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

67 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry